Arkadios Wealth Advisors Cellectis S.A. Transaction History

Arkadios Wealth Advisors

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 19, 2021	SELL	$11.94 - $16.09 $5,838 - $7,868	-489 Closed	0 $0
Q2 2021 Jul 28, 2021	SELL	$14.36 - $20.93 $560 - $816	-39 Reduced 7.39%	489 $7,000
Q1 2021 Apr 26, 2021	BUY	$18.19 - $33.25 $8,076 - $14,763	444 Added 528.57%	528 $10,000
Q4 2020 Feb 09, 2021	BUY	$15.87 - $31.64 $1,333 - $2,657	84 New	84 $2,000

11.2M

2.8K

17.9K

Ticker CLLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,510,800
Market Cap $82.8M
Description
Cellectis S.A., a clinical stage biotechnological company, develops immuno-oncology products based on gene-edited T-cells that express chimeric antigen receptors to target and eradicate cancer cells. It operates through two segments, Therapeutics and Plants. The company is developing UCART19, an allogeneic T-cell product candidate for the treatm...

Get notified when there are updates to the investment portfolio of Arkadios Wealth Advisors, based on Form 13F filings with the SEC.

Stay updated on Arkadios Wealth Advisors with notifications on news.